http://www.finances.com/company-news/51795-nephrogenex-announces-that-the-european-medicines-agency-supports-the-companys-study-design-for-ongoing-trial-in-diabetic-nephropathy.htm NephroGenex Announces that the European Medicines Agency Supports the Company’s Study Design for Ongoing Trial in Diabetic Nephropathy